Yingchuang Future full-link surgical navigation is seeking 10 million RMB in angel round financing.
WinFuture is one of the few full-link intelligent surgical navigation projects in China that has achieved commercial implementation, covering the entire process of pre-operative modeling, pre-operative planning, risk alert, intra-operative navigation, remote assistance and post-operative review. It is currently seeking 10 million yuan in angel round financing, with a post-money valuation reaching 50 million yuan. After obtaining the financing, the enterprise plans to rely on its accumulated benchmark cooperation experience and in-hand orders to quickly seize the primary and sinking markets, so that more primary-level patients can also access precision medical technology.
Industry Background and Policy Tailwinds
At present, the supply-demand structure of China's medical system is undergoing significant changes. According to public data from the National Bureau of Statistics of China, the number of inpatients nationwide reached 312 million in 2024, with the annual total number of surgeries exceeding 104 million, of which complex surgeries of grade III and IV accounted for about 35%, totaling 33.73 million. However, 70% of top-tier tertiary hospitals in China are currently concentrated in urban areas, the shortage of high-caliber medical discipline talents has reached 40%, and most primary medical institutions do not have the capacity to independently carry out high-difficulty complex surgeries, leading to a continuously rising demand for cross-regional precise surgical guidance.
Under the traditional surgical mode, surgeons need to manually complete the 3D reconstruction of more than 200 layers of CT images in their minds. For complex hepatobiliary surgeries, the average duration can reach 4.5 hours, and prolonged cognitive fatigue can easily lead surgeons to make wrong decisions during operations. Clinical data shows that 35% of human vascular variations cannot be predicted in advance through 2D images, which directly increases the probability of surgical complications, and also raises the difficulty and risk of doctor-patient communication.
The continuous implementation of policies at the institutional level has provided solid support for the development of this track. The early "Healthy China 2030" Planning Outline listed the promotion of surgical navigation robots as a core goal to improve clinical precise diagnosis and treatment. Later, the "14th Five-Year Plan" Development Plan for the Medical Equipment Industry jointly issued by ten departments also included intelligent surgical robots as a core key research and development direction. In January 2026, the National Healthcare Security Administration officially released the Guiding Principles for the Establishment of Medical Service Price Items for Surgical and Therapeutic Auxiliary Operations (Trial), which established a nationally unified charging framework for "surgical path navigation auxiliary operations", clarifying that auxiliary operation fees and disposable consumables can be priced separately. Some pilot provinces have previously implemented tiered charging standards for related technologies, completely solving the historical problem of such medical devices being unable to enter hospitals due to "available technologies without charging basis". According to public bidding data, the total amount of winning bids for domestic surgical navigation systems in the first quarter of 2026 reached 206 million yuan. The entire industry is in a stage of rapid initial growth, and the incremental space for domestic substitution and the sinking market is far from being fully released.
Full-Link Technology Has Completed Clinical Verification, Four Categories of Products Cover Multiple Scenarios
The team of WinFuture has spent 8 years on medical-engineering collaborative R&D, developing a full-process intelligent surgical navigation platform covering pre-operative 3D reconstruction, pre-operative planning, risk alert, real-time intra-operative navigation, remote multi-modal assistance, post-operative review and archiving, as well as scientific research and teaching. This technical system has passed the scientific and technological achievement appraisal by the Southwest Information Center of the Ministry of Science and Technology of China, and its overall technical level is recognized as internationally advanced, with its multi-modal mixed reality surgical planning field taking the international leading position. Relevant novelty search reports also confirm that no other similar full-link surgical system integrating mixed reality and digital twin has been reported in public publications so far.
In terms of actual clinical effects, the full closed-loop process built by this technology can reduce the pre-operative planning time for traditional tumor resection from 4 hours to 18 minutes; during the operation, it can realize multi-modal real-time linkage of CT images, 3D models and surgical footage, the real-time calibration error of soft tissue navigation is stably controlled within 0.15mm, and the mixed reality technology can reduce the visual blind area of skull base tumor resection by 82%; after the operation, the system will automatically save the audio and video data of the whole process, which can directly adapt to the teaching needs of clinical departments.
Up to now, this technology has completed clinical verification in more than 4,000 surgeries in total, covering more than 10 clinical departments such as hepatobiliary and pancreatic surgery, urology, and neurosurgery. After application, the duration of relevant surgical operations can be shortened by 10%-30%, the intraoperative blood loss can be reduced by 10%-50%, the number of revisions for radiofrequency puncture is reduced by 2 to 4 times, the blood loss of laparotomy under navigation assistance is only 43% of that in the traditional mode, and the puncture accuracy of the ablation needle can be controlled within 1mm. In addition, 3D visualized pre-operative communication can shorten the communication time with family members by 60%, and the post-operative dispute rate is 42% lower than that of the traditional 2D communication mode. This project has been selected into the first batch of appropriate health technology reserve library of the National Health Commission, and was awarded the 2025 Key Promotion Project of Appropriate Health Technology.
Relying on this core technology, the team has launched four mature end products: the precision surgical auxiliary decision-making system adapted for pre-operative planning, the 5G cross-domain collaboration supported remote intra-operative navigation terminal, the mixed reality wearable navigation device for complex operations, and the desktop interactive teaching terminal adapted for multi-disciplinary consultation, forming a complete product matrix that can cover all clinical scenarios.
Commercial Orders Have Been Implemented, Multiple Paths Guarantee Subsequent Growth
Different from most projects in the same track that are still in the clinical verification stage, WinFuture has now signed three types of commercial orders, forming a diversified profit model of "hardware sales + technical services + long-term operation and maintenance". It has signed equipment purchase and sales contracts with primary county-level medical consortium units, delivering benchmark cases in the primary market; it has signed scientific research service agreements with provincial top tertiary hospitals and other institutions, obtaining stable technical service income; at the same time, it has also signed long-term operation and maintenance and on-site service agreements, providing support for subsequent continuous cash flow, with the customer group covering all types of medical institutions from top tertiary hospitals to primary-level facilities.
Calculated based on the current order implementation progress and industry growth pace, in the third year after obtaining the financing, the company expects its total annual revenue to reach 136.5 million yuan, the overall gross profit margin to rise to 76%, the net profit to exceed 50 million yuan, and the three-year compound annual growth rate to exceed 125%. The 10 million yuan of this financing will be invested in four directions in proportion: 40% for AI algorithm iteration and cutting-edge technology pre-research, 35% for building a regional sales and after-sales system, 15% for upgrading the production workshop that meets the medical device quality management specifications, and the remaining 10% for the construction of a special technology laboratory to match the subsequent order delivery needs.
The core team of this enterprise all have more than 8 years of R&D experience in the field of surgical navigation, and have successively led the formulation of a number of national association standards including Specification for Surgical Navigation Products, Technical Requirements for Neurosurgical Surgical Systems Based on Mixed Reality, and Multi-modal Image Fusion Surgical Navigation System. They have also established long-term industry-university-research cooperation relationships with many universities and medical institutions such as Kunming University of Science and Technology, West China Hospital of Sichuan University, and Shanghai Jiao Tong University. At present, the project has planned three clear exit paths, namely, merger and acquisition by a leading listed company in the medical track, independent application for listing on the Beijing Stock Exchange or the Sci-Tech Innovation Board, and a management buyback fallback plan, which can meet the investment exit needs at different development stages.